Literature DB >> 17106939

Analysis of serum antibody profile against H pylori VacA and CagA antigens in Turkish patients with duodenal ulcer.

Yusuf Erzin1, Sibel Altun, Ahmet Dobrucali, Mustafa Aslan, Sibel Erdamar, Ahmet Dirican, Murat Tuncer, Bekir Kocazeybek.   

Abstract

AIM: To investigate the frequency of seropositivity against CagA, VacA proteins and to determine their independent effects on the development of duodenal ulcer (DU) in Turkish patients.
METHODS: The study was designed as a prospective one from a tertiary referral hospital. Dyspeptic patients who were referred to our endoscopy unit for upper gastrointestinal endoscopy between June 2003 and March 2004 and diagnosed to have DU or nonulcer dyspepsia (NUD) were included. Biopsies from the antrum and body of the stomach were taken in order to assess the current H pylori status by histology, rapid urease test and culture. Fasting sera were obtained from all patients and H pylori status of all sera was determined by IgG antibodies using an enzyme-linked immunosorbent assay (ELISA) kit. All seropositive patients were further analysed using Western blot assays detecting IgG antibodies against CagA and VacA proteins. The c2 test was used for statistical comparison of the values and age-sex adjusted multiple regression analysis was used to determine the independent effects of CagA and VacA seropositivities on the development of DU.
RESULTS: Sixty-three patients with DU and 62 patients with NUD were eligible for the final analysis. Seropositivity for anti-CagA was detected in 51 of 62 (82%), and in 55 of 63 (87%) patients with NUD and DU, respectively (P = no significance), and seropositivity for anti-VacA was found in 25 of 62 (40% ) and in 16 of 63 (25%) patients, with NUD and DU, respectively.
CONCLUSION: These findings suggest that none of these virulence factors is associated with the development of DU in the studied Turkish patients with dyspepsia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17106939      PMCID: PMC4087445          DOI: 10.3748/wjg.v12.i42.6869

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  37 in total

Review 1.  Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise.

Authors:  D Y Graham; Y Yamaoka
Journal:  Helicobacter       Date:  2000       Impact factor: 5.753

Review 2.  Are all helicobacters equal? Mechanisms of gastroduodenal pathology and their clinical implications.

Authors:  A T Axon
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

3.  CagA and the outcome of Helicobacter pylori infection.

Authors:  M J Blaser; J E Crabtree
Journal:  Am J Clin Pathol       Date:  1996-11       Impact factor: 2.493

4.  Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries.

Authors:  Y Yamaoka; T Kodama; O Gutierrez; J G Kim; K Kashima; D Y Graham
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

5.  CagA status in dyspeptic patients with and without peptic ulcer disease in Turkey: association with histopathologic findings.

Authors:  L Demirtürk; A M Ozel; Y Yazgan; E Solmazgül; S Yildirim; M Gültepe; A K Gürbüz
Journal:  Helicobacter       Date:  2001-06       Impact factor: 5.753

6.  The status of the cagA gene does not predict Helicobacter pylori-associated peptic ulcer disease in Singapore.

Authors:  J Hua; P Y Zheng; K G Yeoh; B Ho
Journal:  Microbios       Date:  2000

7.  Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases.

Authors:  W Tee; J R Lambert; B Dwyer
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

8.  Serologic detection of infection with cagA+ Helicobacter pylori strains.

Authors:  T L Cover; Y Glupczynski; A P Lage; A Burette; M K Tummuru; G I Perez-Perez; M J Blaser
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

Review 9.  The vacuolating cytotoxin of Helicobacter pylori.

Authors:  T L Cover
Journal:  Mol Microbiol       Date:  1996-04       Impact factor: 3.501

10.  Role of vacA and the cagA locus of Helicobacter pylori in human disease.

Authors:  M J Blaser
Journal:  Aliment Pharmacol Ther       Date:  1996-04       Impact factor: 8.171

View more
  4 in total

1.  cagA and vacA status and influence of Helicobacter pylori infection on serum oxidative DNA damage in Iranian patients with peptic ulcer disease.

Authors:  Z Khodaii; S M H Ghaderian; R Akbarzadeh Najar; H Nejati; A S Tabatabaei Panah
Journal:  Ir J Med Sci       Date:  2010-08-20       Impact factor: 1.568

2.  The significance of E266K polymorphism in the NOD1 gene on Helicobacter pylori infection: an effective force on pathogenesis?

Authors:  Banu Kara; Hikmet Akkiz; Figen Doran; Suleyman Bayram; Eren Erken; Yuksel Gumurdullu; Macit Sandikci
Journal:  Clin Exp Med       Date:  2009-10-31       Impact factor: 3.984

Review 3.  A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.

Authors:  Elvira Garza-González; Guillermo Ignacio Perez-Perez; Héctor Jesús Maldonado-Garza; Francisco Javier Bosques-Padilla
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

4.  Rapid identification of Helicobacter pylori and assessment of clarithromycin susceptibility from clinical specimens using FISH.

Authors:  Ebru Demiray-Gürbüz; Özlem Yılmaz; Asalia Z Olivares; Can Gönen; Sülen Sarıoğlu; Müjde Soytürk; Sait Tümer; Oğuz Altungöz; İlkay Şimşek; Guillermo I Perez Perez
Journal:  J Pathol Clin Res       Date:  2016-11-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.